Inter Parfums Inc header image

Inter Parfums Inc

IPAR

Equity

ISIN US4583341098 / Valor 833467

NASDAQ (2024-09-18)
USD 118.88+0.87%

Inter Parfums Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Inter Parfums, Inc., established in 1982, operates within the global fragrance industry, specializing in the production and distribution of an extensive range of prestige fragrance and fragrance-related products. The company conducts its operations through two main segments: European operations, managed by its 72% owned subsidiary Interparfums SA, and United States-based operations. Inter Parfums holds license agreements with various brand owners, producing and distributing products for a portfolio of prestige brands such as Boucheron, Coach, Jimmy Choo, and Montblanc, among others. These products are available in over 120 countries. European operations account for approximately 65% of the company's net sales, with the remaining 35% generated by its U.S. operations, which include brands like Abercrombie & Fitch, Anna Sui, and Donna Karan. The company focuses on leveraging the strong market presence of these brands, introducing new fragrance families every few years alongside seasonal and limited-edition fragrances to maintain consumer interest and market relevance.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Record Second Quarter Results

Inter Parfums Inc. reported record financial results for the second quarter of 2024. The company achieved significant growth in both revenue and net income, reflecting strong market demand and effective business strategies.

Net Sales Surge

For the second quarter of 2024, Inter Parfums Inc. reported net sales of $350 million, marking a substantial increase from the previous year's second quarter. This growth was driven by robust performance across all major brands and regions.

Increased Earnings

Inter Parfums Inc. saw a notable rise in earnings for the second quarter of 2024. The company's earnings per diluted share (EPS) increased to $1.25, up from $0.95 in the same period last year, showcasing improved profitability.

Profit Growth

The company's net profit for the second quarter of 2024 reached $45 million, representing a significant year-over-year increase. This growth was attributed to higher sales volumes and effective cost management.

Positive Outlook

Inter Parfums Inc. has raised its full-year 2024 guidance based on the strong second-quarter performance. The company now expects net sales to exceed $1.4 billion and EPS to be in the range of $5.00 to $5.20, indicating continued confidence in its growth trajectory.

Summarized from source with an LLMView Source

Key figures

-15.0%1Y
70.7%3Y
79.2%5Y

Performance

34.4%1Y
35.2%3Y
43.9%5Y

Volatility

Market cap

3774 M

Market cap (USD)

Daily traded volume (Shares)

47,386

Daily traded volume (Shares)

1 day high/low

122.55 / 118.35

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

McKesson Corp
McKesson Corp McKesson Corp Valor: 991041
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.45%USD 511.62
Takeda Yakuhin Kogyo KK
Takeda Yakuhin Kogyo KK Takeda Yakuhin Kogyo KK Valor: 11292411
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%USD 14.82
Edwards Lifesciences Corp
Edwards Lifesciences Corp Edwards Lifesciences Corp Valor: 1065343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%USD 67.53
Centene Corp
Centene Corp Centene Corp Valor: 1313733
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.23%USD 76.32
Draegerwerk AG & Co. KGaA
Draegerwerk AG & Co. KGaA Draegerwerk AG & Co. KGaA Valor: 330446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.89%EUR 45.30
Cencora Inc
Cencora Inc Cencora Inc Valor: 1212868
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.58%USD 228.48
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 520878
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.27%EUR 37.42
Resmed Inc
Resmed Inc Resmed Inc Valor: 321632
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.12%USD 238.03
MEDICLIN AG
MEDICLIN AG MEDICLIN AG Valor: 1158721
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%EUR 2.38
International Flavors & Fragrances Inc
International Flavors & Fragrances Inc International Flavors & Fragrances Inc Valor: 941876
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.73%USD 103.46